Skip to content

Bidirectional cohort study on high risk factors of cerebral infarction after revascularization in moyamoya disease

Bidirectional cohort study on high risk factors of cerebral infarction after revascularization in moyamoya disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060583
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-03-29
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

Sponsors

Beijing Tiantan Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Moyamoya Disease: DSA or MRI examination conforms to the Diagnosis and Treatment of Moyamoya Disease (Guidelines for Moyamoya Disease, NeurolMed Chir (Tokyo) 245-266, 2012), characterized by unexplained stenosis or occlusion of the distal parts of one or both internal carotid arteries, anterior cerebral arteries, and/or initial parts of middle cerebral arteries, accompanied by dilation of the perforating arteries at the bottom of the brain or of capillaries at the surface of the brain, i.e., the formation of smokelike vessels; 2. Signed informed consent (ICF); 3. Older than 18 and younger than 55 years old; 4. The education level of the patients has reached primary school or above (education years >= 6).

Exclusion criteria

Exclusion criteria: 1. Patients with immune system diseases resulting in vascular lesions; 2. Patients who cannot receive revascularization surgery; 3. There are other neuropsychiatric diseases that affect cognitive function (such as Alzheimer's disease, Parkinson's disease, depression, anxiety, cerebral hemorrhage, hydrocephalus, craniocerebral trauma, etc.); 4. Patients with contraindications to MRI examination (patients with cardiac pacemaker, nerve stimulator, artificial metal heart valve and other metal foreign bodies, etc.) or unable to complete image collection.

Design outcomes

Primary

MeasureTime frame
DSA;Computed Tomography;

Countries

China

Contacts

Public ContactRong Wang

Beijing Tiantan Hospital affiliated to Capital Medical University

ronger090614@ccmu.edu.cn+86 13001190333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026